Thursday, May 12, 2022

Pfizer launches COVID-19 vaccine test in children as new data support mRNA shots in pregnant women


While COVID-19 shots have proven effective in clinical trials—and now in the real world, too—relatively little is known about how they work in children and pregnant women. Moderna, Pfizer and Johnson & Johnson aim to change that.

Just as data are showing mRNA shots work in pregnant women, Pfizer has started testing its shot in children aged 6 months to 11 years. That pediatric trial follows a similar move by Moderna earlier this month.

Pfizer and its partner BioNTech are running a Phase 1/2/3 dose-escalation study in three age groups—5 to 11, 2 to 5 and 6 months to 2 years. The companies may run a study in infants under 6 months “once an acceptable safety profile has been established.” 

Moderna, for its part, started a phase 2/3 study in children under 12 years of age earlier this month. That study will start first in older children, and once investigators determine the shot to be safe, they’ll move to test the shot in younger children, Forbes reports

Johnson & Johnson has said it’s planning various studies in children and pregnant women, The New York Times reports.

Even as vaccines reach millions of Americans daily, vaccinating children is seen as a key step in reaching herd immunity to beat back the pandemic. During a recent Senate hearing, the Biden administration’s chief medical adviser, Anthony Fauci, said the United States will need to vaccinate children to reach herd immunity. 

Pfizer’s vaccine is authorized for people 16 and older, while Moderna and Johnson & Johnson are authorized for people 18 and older. 

RELATED: Pfizer aims to ship COVID-19 vaccine doses ‘within hours’ of regulatory nods, CEO says. Will a ‘race to regulate’ ensue? 

Meanwhile, a new study in the American Journal of Obstetrics and Gynecology found the mRNA shots from Pfizer and Moderna to be effective in pregnant and lactating women.  

Pregnant women who received the vaccines had higher antibody counts than those who had recovered from a COVID-19 infection, the researchers found, and they passed antibodies along to their newborns. Pregnant women were excluded from initial COVID-19 clinical trials, so data had been scarce until now.

RELATED: ‘Very soon,’ says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data 

Since the Pfizer and Moderna vaccines won emergency FDA authorizations late last year, more than 133 million COVID-19 shots have been administered, the CDC says.

The total now includes millions of vaccinations using the single-dose J&J shot, which won an authorization in late February. Vaccine supply is expected to ramp up considerably in the coming weeks. 





Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...